Test Price
2,800 AED✅ Home Collection Available
MITF Gene Tietz Albinism‑Deafness Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
The MITF gene test delivers definitive molecular diagnosis for Tietz syndrome with 99.9% diagnostic sensitivity through ISO‑accredited next‑generation sequencing. Full‑service logistics include VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection, with post‑test clinical guidance and insurance verification via WhatsApp.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (daily 8 AM‑11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in Result Interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This NGS‑based test analyses the entire coding region of the MITF gene to detect pathogenic variants responsible for Tietz syndrome, a rare autosomal dominant disorder characterised by congenital sensorineural hearing loss and generalised oculocutaneous albinism. The assay provides definitive molecular confirmation to guide personalised clinical management.
| Feature | Our MITF NGS Test | Closest Alternative Panel |
|---|---|---|
| Diagnostic Precision | Full gene sequencing with 99.9% sensitivity | Limited to hotspot mutations only |
| Methodology | NGS (Next‑Generation Sequencing) on Illumina platform | Sanger sequencing of select exons |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
“A confirmed MITF mutation provides a robust diagnosis of Tietz syndrome, but integration with comprehensive audiometric, dermatological, and ophthalmological evaluations is essential. Pre‑ and post‑test genetic counselling is mandatory, especially for family planning and early intervention strategies.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Advisory
This genetic test should never replace urgent clinical assessment for sudden hearing loss, acute visual changes, or rapidly evolving pigmentation anomalies. Always consult a specialist before initiating any diagnostic workup.
Exclusion Criteria & Emergency Red Flags
- Not intended for asymptomatic individuals without a family history of Tietz syndrome unless advised by a clinical geneticist.
- Prenatal testing requires multidisciplinary genetic counselling and is performed strictly under approved UAE guidelines.
- Red Flags: Sudden profound hearing loss, acute visual changes, or rapidly changing skin pigmentation warrant immediate ENT/dermatology assessment.
Patient FAQ & Clinical Guidance
1. What is Tietz syndrome and what does the MITF gene test detect?
This NGS‑based MITF gene test identifies mutations causing Tietz syndrome, a rare genetic disorder combining congenital sensorineural deafness with generalised oculocutaneous albinism. The assay provides definitive molecular diagnosis.
2. Who should consider this genetic test?
Individuals with unexplained congenital hearing loss and albinism, or a positive family history of Tietz syndrome, should undergo MITF gene testing after formal genetic counselling.
3. What sample is required and how long do results take?
A whole blood sample, extracted DNA, or a dried blood spot on an FTA card is accepted. The final report is delivered within 3 to 4 weeks.
UAE Regulatory & Data Privacy Adherence
This test is performed at DNA Labs UAE, DHA Facility License No. 1143, located at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. All clinical data handling complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient safety and consent procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | MITF Gene Tietz Albinism‑Deafness Syndrome Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or dried blood spot |
| Methodology Used | Next‑Generation Sequencing (NGS) on Illumina platform |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 81438-1 |
| DHA Facility License & Laboratory Address | License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians